Skip to main content

CORRECTION article

Front. Cardiovasc. Med., 21 April 2023
Sec. Atherosclerosis and Vascular Medicine
Volume 10 - 2023 | https://doi.org/10.3389/fcvm.2023.1179643

Corrigendum: The dual role of low-density lipoprotein receptor–related protein 1 in atherosclerosis

This article is a correction to:

  1. The Dual Role of Low-Density Lipoprotein Receptor-Related Protein 1 in Atherosclerosis

    1. Read original article
\r\nJiefang Chen&#x;Jiefang Chen†Ying Su&#x;Ying Su†Shulan PiShulan PiBo Hu Bo Hu*Ling Mao \r\nLing Mao*
  • Department of Neurology, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China

A Corrigendum on

The dual role of low-density lipoprotein receptor-related protein 1 in atherosclerosis

By Chen J, Su Y, Pi S, Hu B, Mao L. (2021) Front Cardiovasc Med. 8:682389. doi: 10.3389/fcvm.2021.682389

Missing Citation

In the published article, (75) was not cited in the article. The citation has now been inserted in [INTRODUCTION TO LRP1], [Structure of LRP1], [Paragraph one], and the text should read:

“[Like all members of the LDL receptor family, LRP1 consists of five modular structural units: cysteinerich complement-type repeats (CRs), EGF precursor repeats, β-propeller (YWTD) domains, a transmembrane domain, and a cytoplasmic domain (Figure 1) (75).]”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Error in Figure Legend

In the published article, there was an error in the legend for (Figure 1) as published. (A note regarding the original image of Figure 1 was missing.) The corrected legend appears below.

[FIGURE 1 Structure of mature low-density lipoprotein receptor–related protein-1 (LRP-1). LRP1 is a multifunctional receptor that binds a large spectrum of extracellular and intracellular ligands. The α chain contains long modular arrays of acidic cysteine-rich complement-type repeats (CRs), along with epidermal growth factor (EGF)-like domains and β-propeller modules. Also, it consists of four ligand-binding regions (I, II, III, and VI), which are composed of 2, 8, 10, and 11 CRs, respectively. The cytoplasmic tail contains two NPxY motifs that are required for endocytosis and multiple signaling pathways. LRP1 has an YXXL motif adjacent to the second NPxY motif, enabling rapid endocytosis. The β chain also interacts with scaffolding proteins such as PSD-95, Dab-1, and FE-65. Regions II and IV bind most of the currently mapped known ligands of LRP1. β-Secretase (BACE1) cleaves the extracellular domain of LRP1 to form sLRP1 and LRP1-CTF (LRP1-C-terminal fragment). Both extra- and intracellular chains can act independently of each other when the α chain is shed as a soluble LRP1 and the β chain translocates to the nucleus and activates gene transcription and signaling cascades. LPL, lipoprotein lipase; ApoE, apolipoprotein E; COOH, carboxy terminal; EGF, epidermal growth factor; NH2, amino terminal. The image of Figure 1 was modified from the reference (75), adding details to the pictures of the ligands of LRP1.]

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Reference

75. Emonard H, Théret L, Bennasroune AH, Dedieu S. Regulation of LRP-1 expression: make the point. Pathol Biol (Paris). (2014) 62(2):84–90. doi: 10.1016/j.patbio.2014.02.00224661974

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: LRP1, adipocytes, atherosclerosis, endothelial cells, immune cells, macrophages, smooth muscle cells

Citation: Chen J, Su Y, Pi S, Hu B and Mao L (2023) Corrigendum: The dual role of low-density lipoprotein receptor–related protein 1 in atherosclerosis. Front. Cardiovasc. Med. 10:1179643. doi: 10.3389/fcvm.2023.1179643

Received: 4 March 2023; Accepted: 7 March 2023;
Published: 21 April 2023.

Approved by: Frontiers in Cardiovascular Medicine, Frontiers Media SA, Switzerland

© 2023 Chen, Su, Pi, Hu and Mao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ling Mao maoling@hust.edu.cn Bo Hu hubo@hust.edu.cn

†These authors have contributed equally to this work and share first authorship

Specialty Section: This article was submitted to Atherosclerosis and Vascular Medicine, a section of the journal Frontiers in Cardiovascular Medicine

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.